Related Experiment Video

Updated: Jun 25, 2026

Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice
08:55

Nasal Potential Difference to Quantify Trans-epithelial Ion Transport in Mice

Published on: July 4, 2018

Suppression of nonsense mutations in Rett syndrome by aminoglycoside antibiotics

Cornelia Brendel1, Edith Klahold, Jutta Gärtner

  • 1Department of Pediatrics and Pediatric Neurology, Georg August University, Göttingen, D-37075 Germany.

Pediatric Research
|February 5, 2009
PubMed

Insights

Gentamicin can induce read-through of nonsense mutations in the MECP2 gene, offering potential for Rett Syndrome (RTT) therapy. This in vitro study demonstrated functional full-length protein expression, comparable to other genetic disorders.

Area of Science:

  • Genetics
  • Molecular Biology
  • Neuroscience

Background:

  • Rett Syndrome (RTT) is a neurodevelopmental disorder primarily caused by nonsense mutations in the MECP2 gene.
  • Currently, no curative therapies exist for RTT.
  • Aminoglycosides have shown potential in other genetic disorders by promoting read-through of nonsense mutations.

Purpose of the Study:

  • To investigate the efficacy of aminoglycoside-induced read-through for MECP2 nonsense mutations in RTT.
  • To evaluate if this therapeutic strategy is applicable to Rett Syndrome.

Main Methods:

  • HeLa cells were transfected with MECP2 mutant alleles.
  • Cells were treated with gentamicin to induce nonsense mutation read-through.
  • Full-length protein expression was analyzed using Western blotting and immunofluorescent staining.

Main Results:

  • Gentamicin treatment resulted in a MECP2 nonsense mutation read-through efficiency ranging from 10% to 21.8%.
  • The read-through efficiency varied based on the nucleotide sequence context of the nonsense mutation.
  • The expressed full-length MECP2 protein was correctly localized to the nucleus.

Conclusions:

  • Aminoglycoside-mediated read-through of MECP2 nonsense mutations is achievable in vitro.
  • This approach shows potential as a therapeutic strategy for Rett Syndrome.
  • The observed in vitro efficiency is comparable to that seen in other genetic disorders.

More Related Videos

A Non-random Mouse Model for Pharmacological Reactivation of Mecp2 on the Inactive X Chromosome08:27

A Non-random Mouse Model for Pharmacological Reactivation of Mecp2 on the Inactive X Chromosome

Published on: May 22, 2019

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia05:51

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

Related Concept Videos

Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...